Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Melanoma 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Hepatocellular 4Breast Neoplasms 4Urinary Bladder Neoplasms 3Stomach Neoplasms 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Merkel Cell 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Small Cell Lung Cancer Recurrent 1Safety Issues 1Recurrent Liver Cancer After Liver Transplantation 1Recurrence 1Radiation Pneumonitis 1Ovarian Neoplasms 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Lymphoma 1Lung Neoplasms 1Locally Advanced or Metastatic Solid Tumors 1Liver Neoplasms 1Kidney Neoplasms 1Hodgkin Disease 1

Interventions

tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1durvalumab 1camrelizumab 1beclomethasone 17-monopropionate 1aumolertinib 1atezolizumab 1Radiotherapy 1Nivolumab 1Nicorandil 1Immunotherapy 1Cisplatin 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Radiation Pneumonitis × atezolizumab × Clear all
NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Zhejiang Cancer Hospital

Phase 3 Unknown
105 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡